Man H. Oh

Cheonan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis.

Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis.

Journal: FEBS letters

Published: May 26, 2026

An overview of outer membrane protein A (OmpA) as a therapeutic target for Acinetobacter baumannii infection.

An overview of outer membrane protein A (OmpA) as a therapeutic target for Acinetobacter baumannii infection.

Journal: Expert opinion on therapeutic targets

Published: May 08, 2026

Antisense peptide nucleic acids targeting ribosomal protein genes: A novel strategy against carbapenem-resistant Acinetobacter baumannii.

Antisense peptide nucleic acids targeting ribosomal protein genes: A novel strategy against carbapenem-resistant Acinetobacter baumannii.

Journal: Molecular therapy. Nucleic acids

Published: January 06, 2026

Comprehensive in silico analysis of Acinetobacter isolates from South Korea reveals genomic diversity, antimicrobial resistance, virulence factors, and evolutionary dynamics.

Comprehensive in silico analysis of Acinetobacter isolates from South Korea reveals genomic diversity, antimicrobial resistance, virulence factors, and evolutionary dynamics.

Journal: Genes & genomics

Published: August 21, 2025

Erratum for Woo et al., "Acinetobacter baumannii OmpA hinders host autophagy via the CaMKK2-reliant AMPK-pathway".

Erratum for Woo et al., "Acinetobacter baumannii OmpA hinders host autophagy via the CaMKK2-reliant AMPK-pathway".

Journal: mBio

Published: May 08, 2025

In silico screening of epitopes as potential vaccine candidates against pathogenic Acinetobacter baumannii.

In silico screening of epitopes as potential vaccine candidates against pathogenic Acinetobacter baumannii.

Journal: Genes & genomics

Published: March 18, 2025

AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA.

AbOmpA in Acinetobacter baumannii: exploring virulence mechanisms of outer membrane-integrated and outer membrane vesicle-associated AbOmpA and developing anti-infective agents targeting AbOmpA.

Journal: Journal of biomedical science

Published: March 12, 2025

Acinetobacter baumannii OmpA hinders host autophagy via the CaMKK2-reliant AMPK-pathway.

Acinetobacter baumannii OmpA hinders host autophagy via the CaMKK2-reliant AMPK-pathway.

Journal: mBio

Published: February 25, 2025

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Acinetobacter baumannii Infections.

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Acinetobacter baumannii Infections.

Journal: Pathogens (Basel, Switzerland)

Published: November 04, 2024

Comparative genomic and phenotypic analysis of low- and high-virulent Acinetobacter baumannii strains: Insights into antimicrobial resistance and virulence potential.

Comparative genomic and phenotypic analysis of low- and high-virulent Acinetobacter baumannii strains: Insights into antimicrobial resistance and virulence potential.

Journal: Microbial pathogenesis

Published: September 09, 2024

Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii.

Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii.

Journal: Frontiers in cellular and infection microbiology

Published: July 10, 2024

Identification and characterization of Acinetobacter nosocomialis BfmRS, two-component regulatory system, essential for biofilm development.

Identification and characterization of Acinetobacter nosocomialis BfmRS, two-component regulatory system, essential for biofilm development.

Journal: Genes & genomics

Published: February 18, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026